Current Fellows in the Clinical Genetics Branch

Dr. de Andrade studies genetic and behavioral factors that could be associated with cancer risk, progression, and phenotypic variability in Li-Fraumeni Syndrome patients.

Ms. Bess works on projects in the Clinical Genetics Branch and the Connect for Cancer Prevention Cohort Study in the Trans-Divisional Research Program.

Dr. Chapman Hannah develops machine learning and statistical strategies to identify novel pathogenic variants in pediatric cancer.

Dr. Forbes Shepherd studies Li-Fraumeni syndrome and inherited bone marrow failure systems in order to develop psychosocial interventions for young people with high genetic risk of cancer.

Dr. Rajender Kumar is working on developing image-based AI algorithms for classification of oral precancer and cancer.

Dr. Kundrod investigates approaches to HPV detection that have the potential to reduce cervical cancer disparities.

Dr. Landy studies the natural history of human papillomavirus-related oropharyngeal cancers, and the appropriate use of risk estimation methods when evaluating cancer screening.

Dr. Mendez investigates accelerated aging and biomarkers of aging among people who have received a hematopoietic stem cell transplant.

Ms. Nagarkar investigate telomere function genes associated with numerous diseases including thyroid cancer, Coats plus syndrome, and melanoma.

Dr. Nelson focuses on characterizing the molecular evolution of oncogenic Human Papillomaviruses (HPVs) and their relationships to disease progression.

Ms. Nurelegne studies genetic mutations associated with bone marrow failure called Dyskeratosis congenita, and pulmonary fibrosis.

Mr. O'Donnell is building and validating absolute risk prediction models for ovarian cancer, among other projects.

Dr. Pearce is working with Sharon A. Savage, M.D., to study telomere length measurement and how donor telomere length impacts recipient survival after hematopoietic cell transplantation.

Dr. Pirsl focuses on identifying associations of genetic markers with outcomes of hematopoietic stem cell transplant as well as sampling and healthy volunteer effects in cancer cohort studies.

Dr. Rising focuses her research on developing a better understanding of health behaviors, communication behaviors, and psychosocial needs of individuals and families living with cancer predisposition syndromes.

Dr. Wijayabahu focuses on understanding etiological relationships and modifiable risk factors of cancers that afflict women.